Millennium's Velcade approved for second round of treatment in relapsed patients

The flagship blood cancer drug developed by local drug company Millennium: The Takeda Oncology Company and approved 11 years ago has gotten further approval for retreatment of patients who have responded to the drug in the past, but whose cancer has since relapsed...